Molecular Mechanisms and Therapy of Gliomas

A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Neurobiology and Clinical Neuroscience".

Deadline for manuscript submissions: closed (30 April 2024) | Viewed by 295

Special Issue Editor


E-Mail Website
Guest Editor
Department of Diagnostics and Public Health, P.le L.A. Scuro, University of Verona, 37129 Verona, Italy
Interests: cancer biology; colorectal cancer; neuropathology; surgical pathology; prognostic markers; cancer biomarkers; cancer diagnostics; molecular biology
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

In recent years, knowledge of the molecular landscape of gliomas has greatly expanded. It has been shown that histologically similar tumors display distinct epigenetic, genetic, transcriptomic, and proteomic features and that the clinical outcome of gliomas can be better predicted by integrating histological and molecular data rather than by histology. This has led to the development of novel glioma classification schemes. Indeed, the latest World Health Organization Classification of gliomas, published in 2021, subdivided gliomas not only on their growth pattern, that is, diffuse or circumscribed, on their histopathological features and on their anatomical location, but also on genetic alterations. In addition, the essential diagnostic criterion for some tumor types is a unique DNA methylation profile.

An increasing understanding of the molecular features of gliomas has also led to the identification of novel potential therapeutic targets.

This Special Issue aims to collect papers on recent advances in the molecular mechanisms of glioma pathogenesis and progression and on novel therapeutic strategies for these tumors.

Dr. Valeria Barresi
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • glioma
  • epigenetic
  • methylome
  • therapy
  • genetic alteration
  • transcriptomic
  • proteomic

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop